Trial Profile
A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 30 Nov 2023
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary) ; Indometacin
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2023 Planned End Date changed from 1 Feb 2024 to 1 Dec 2024.
- 28 Nov 2023 Planned primary completion date changed from 1 Jul 2023 to 1 Mar 2024.
- 24 Apr 2023 Planned End Date changed from 1 Jun 2023 to 1 Feb 2024.